Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,634

Stocks News & Analysis

stocks

Fears of deteriorating loan quality sends bank share plummeting

We maintain our fair value estimate despite unfavourable economic conditions.
stocks

Why it’s not all bad news for Flight Centre following downgrade

Despite an earnings downgrade, shares in FLT remain undervalued.
stocks

Chart of the Week: What 650 IPOs reveal about long-term performance

Our data shows buying into the IPO hype can be costly.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,964.201.20-0.01%
CAC 408,384.8746.74-0.55%
DAX 4024,671.22323.61-1.29%
Dow JONES (US)51,876.1144.51-0.09%
FTSE 10010,508.0221.87-0.21%
HKSE22,671.86405.05-1.76%
NASDAQ25,297.6260.99-0.24%
Nikkei 22569,360.883,005.46-4.15%
NZX 50 Index13,495.242.190.02%
S&P 5007,354.023.47-0.05%
S&P/ASX 2008,764.200.200.00%
SSE Composite Index4,027.2693.02-2.26%

Market Movers